-

SHAREHOLDER BUYOUT ALERT: Kaskela Law LLC Announces Fairness Investigation Into Dun & Bradstreet Holdings, Inc. (NYSE: DNB) Proposed Stockholder Buyout and Encourages Investors to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--The law firm of Kaskela Law LLC announces that it is investigating the fairness of the recently announced proposed buyout of Dun & Bradstreet Holdings, Inc. (NYSE: DNB) (“DNB”) shareholders.

Click here for additional information: https://kaskelalaw.com/case/dun-bradstreet/.

On March 24, 2025, DNB announced that it had agreed to be acquired by private equity firm Clearlake Capital Group, L.P. at a price of $9.15 per share in cash. Following the closing of the proposed transaction, DNB’s current stockholders will be cashed out of their investment position and the company’s shares will no longer be publicly traded.

The investigation seeks to determine whether DNB shareholders are set to receive sufficient monetary consideration for their shares, and whether the company’s officers and/or directors breached their fiduciary duties or violated the securities laws in agreeing to sell the company at $9.15 per share. Notably, shares of DNB’s common stock traded above $12.00 per share as recently as February 2025, and at the time the proposed transaction was announced, several stock analysts were maintaining price targets for the company’s shares above the proposed buyout price.

DNB shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750 for additional information about this investigation and their legal rights and options.

Alternatively, investors may submit their information to the firm by clicking on the following link (or if necessary, by copying and pasting the link into your browser):

https://kaskelalaw.com/case/dun-bradstreet/

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent basis, which means that the firm’s clients never pay any out-of-pocket costs for legal representation. For additional information about Kaskela Law LLC, including the firm’s recent notable recoveries for investors, please visit www.kaskelalaw.com.

This notice may constitute attorney advertising in certain jurisdictions.

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq. 
(skaskela@kaskelalaw.com
Adrienne Bell, Esq. 
(abell@kaskelalaw.com
18 Campus Blvd., Suite 100 
Newtown Square, PA 19073 
(484) 229 – 0750 
www.kaskelalaw.com

Kaskela Law LLC

NYSE:DNB

Release Versions

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq. 
(skaskela@kaskelalaw.com
Adrienne Bell, Esq. 
(abell@kaskelalaw.com
18 Campus Blvd., Suite 100 
Newtown Square, PA 19073 
(484) 229 – 0750 
www.kaskelalaw.com

More News From Kaskela Law LLC

Kaskela Law Firm Reports Ongoing Shareholder Investigation of Reservoir Media, Inc. and Encourages Investors to Contact the Firm – RSVR

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law is investigating Reservoir Media, Inc. (NASDAQ: RSVR) on behalf of the company's shareholders....

Kaskela Law Firm Reports Ongoing Shareholder Investigation of Priority Technology Holdings, Inc. and Encourages Investors to Contact the Firm – PRTH

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC is conducting a stockholder investigation into Priority Technology Holdings, Inc. (NASDAQ: PRTH) (“Priority Technology”). The investigation seeks to determine whether Priority Technology and/or the company’s representatives violated the securities laws or breached their fiduciary duties in connection with recent corporate actions. Priority Technology shareholders should contact Kaskela Law (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 2...

SELECT MEDICAL STOCK ALERT: Does $16.50 Per Share Represent a Fair Shareholder Buyout Price? Kaskela Law Firm Announces Investigation into Fairness of Buyout Offer and Encourages Investors to Contact the Firm – SEM

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC is investigating the recently announced buyout of Select Medical Holdings Corp. (“Select Medical”) (NYSE: SEM) shareholders to determine whether the $16.50 per share buyout offer is fair to the company’s investors or if it undervalues the company’s shares. Click here for additional information: https://kaskelalaw.com/case/select-medical/ On March 2, 2026, Select Medical announced that it had agreed to be acquired by an investment consortium at a pr...
Back to Newsroom